Apply

Ready to go for it?

AI Apply speeds things up—apply directly if you prefer.

FREE ACCESS
5,000–10,000 jobs/day
Scoutfield Logo

See all jobs on Scoutfield

Search thousands of fresh jobs every day.

Discover
  • Fresh listings
  • Fast filters
  • No subscription required
Create a free account and start exploring right away.
AstraZeneca

Associate Director, Translational Medicine Lead

AstraZeneca

. Own and execute end-to-end translational strategies for B-cell malignancy programs from preclinical through Phase 1/2 and, as needed, Phase 3 .

Posted 10/20/2026full-timeUnited StatesSenior💰 $142,378 - $213,566 per yearWebsite

Core Competencies

Role fit
Core Competencies

Use this summary to align your resume positioning with the role.

Demonstrates expertise in B-cell malignancy biology and translational strategies, with a strong focus on biomarker technologies and early-phase oncology clinical trials. Proven ability to lead cross-functional teams and integrate scientific data for informed decision-making.

Highest-signal resume keywords
PhD In Biological ScienceExperience With T-Cell Engaging BispecificsExpertise In Biomarker TechnologiesKnowledge Of B-Cell Malignancy BiologyUnderstanding Of Clinical Development Process

ATS Keywords

Tailor your resume
Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills
Biomarker Plan DevelopmentProtocol InputSample AnalysisFlow CytometryImmunohistochemistryMolecular ProfilingNGSCtDNACytokine ProfilingMRD Assessment
Soft Skills
Excellent CommunicationPresentation SkillsScientific LeadershipAbility To Work IndependentlyAbility To Operate Effectively In Teams
Tools & Technologies
Fit-For-Purpose AssaysCross-Functional Team CollaborationRegulatory Expectations For Biomarker ValidationCDx Development
Industry Keywords
Hematology-OncologyImmunologyOncologyMolecular BiologyB-ALLB-CLLNHLTherapeutic ResistanceTumor MicroenvironmentSmall-Molecule Hematology Therapeutics

Tech Stack

Tools & technologies
Go

About the role

Key responsibilities & impact
  • Own and execute end-to-end translational strategies for B-cell malignancy programs from preclinical through Phase 1/2 and, as needed, Phase 3
  • Define indications, stratify patients, and refine target populations using human genetics, expression, and clinical data
  • Design and interpret target-engagement and pharmacodynamic biomarker readouts for dose selection and proof of mechanism
  • Investigate resistance mechanisms using longitudinal and relapse samples
  • Analyze B-cell tumor biology, pathway interactions, and tumor microenvironment features to guide combinations
  • Lead development, validation, and deployment of fit-for-purpose assays internally and with external laboratories/CROs
  • Embed biomarker strategies and endpoints into protocols, sample manuals, and statistical plans
  • Partner with biosamples and precision diagnostics teams on collection, traceability, and CDx alignment
  • Represent Translational Medicine on cross-functional teams and connect insights across the B-cell portfolio
  • Contribute to governance materials, study reports, Go/No-Go recommendations, health authority interactions, and filings
  • Present scientific narratives internally and in external forums

Requirements

What you’ll need
  • PhD in a relevant biological science, including hematology-oncology, immunology, oncology, molecular biology, or related field
  • Postdoctoral and/or industry experience required
  • 0–3+ years of experience with T-cell engaging bispecifics in an oncology/hematology development context
  • Demonstrated experience with antibody-drug conjugates in a hematology or oncology development context
  • Experience contributing to early-phase oncology clinical trials, including biomarker plan development, protocol input, and sample analysis
  • Expertise in biomarker technologies including flow cytometry, immunohistochemistry, molecular profiling, NGS, ctDNA, MRD assessment, cytokine/immune profiling, and other omics-based approaches
  • Knowledge of B-cell malignancy biology spanning B-ALL, B-CLL, and NHL, including disease pathogenesis, standard-of-care landscape, and therapeutic resistance
  • In-depth understanding of immunology and the tumor microenvironment in B-cell cancers
  • Understanding of the end-to-end clinical development process from dose escalation through registration
  • Ability to work independently and deliver translational programs with regular managerial support
  • Ability to operate effectively and demonstrate scientific leadership within cross-functional teams in a matrixed pharma or biotech environment
  • Ability to integrate scientific data and articulate implications for Go/No-Go decisions
  • Excellent communication and presentation skills
  • Desired: experience with small-molecule hematology therapeutics, cell therapy programs, MRD methodologies, multi-omic biomarker data, regulatory expectations for biomarker validation/CDx development, and mentoring junior scientists

Benefits

Comp & perks
  • Short-term incentive bonuses
  • Equity-based awards for salaried roles
  • Qualified retirement programs
  • Paid time off, including vacation, holiday, and leaves
  • Health coverage
  • Dental coverage
  • Vision coverage
  • Flexible working arrangements alongside the expectation of office attendance
  • Disability or special-needs accommodation